Experimental therapy crosses blood-brain barrier to treat neurological disease
Monday, February 4, 2013 - 21:00
in Biology & Nature
Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice. Scientists say the study provides a non-invasive procedure that targets the blood-brain barrier and can be tested for delivering large-molecule therapeutic agents to treat neurological disorders.